PharmGKB contains no dosing guidelines for this drug class. To report known genotype-based dosing guidelines, or if you are interested in developing guidelines, click here.
PharmGKB contains no drug labels with pharmacogenomic information for this drug class. To report a drug label with PGx, click here.
PharmGKB contains no clinical annotations for this drug class. To report clinical variants, click here.
PharmGKB contains no genetic testing information for this drug class. To report genetic tests, click here.
Overview
Generic Names
Trade Names
Brand Mixture Names
PharmGKB Accession Id:
PA1102
ATC Therapeutic Category
- X.04:QT-Prolonging Drugs
Publications related to qt-prolonging drugs: 1
|
Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science (New York, N.Y.). 2002. Splawski Igor, et al. [Article:12193783@PubMed] |